Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib

  • Maya N. White
  • , Andrew J. Piper-Vallillo
  • , Rebecca M. Gardner
  • , Kristen Cunanan
  • , Joel W. Neal
  • , Millie Das
  • , Sukhmani K. Padda
  • , Kavitha Ramchandran
  • , Thomas T. Chen
  • , Lecia V. Sequist
  • , Zofia Piotrowska
  • , Heather A. Wakelee

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science